Literature DB >> 16718758

Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis.

Kazunari Murakami1, Masaaki Kodama, Toshio Fujioka.   

Abstract

There appears to be the strong association between Helicobacter pylori (H pylori) and gastric cancer. We reviewed the latest evidences about the effects of H pylori infection on gastric carcinogenesis, classified into epidemiology, dynamics of gastric mucosal changes, DNA damages, virulence factors, host factors, and source of gastric malignancy. Through the considerable progress made in research into virulence factors resulting from differences between H pylori strains, such as cagA positivity, as well as into host factors, such as gene polymorphisms, a diverse spectrum of H pylori-associated diseases, including gastric cancer, is beginning to lend itself to elucidation. The impact of the novel hypothesis advanced by Houghton et al proposing bone-marrow derived stem cells (BMDC) as a potential source of gastric malignancy on evolving research remains to be seen with interest. Further progress in research into H pylori eradication as a viable prophylaxis of gastric cancer, as well as into the mechanisms of gastric carcinogenesis, is to be eagerly awaited for the current year and beyond.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718758      PMCID: PMC4130980          DOI: 10.3748/wjg.v12.i17.2713

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  56 in total

1.  SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein.

Authors:  Hideaki Higashi; Ryouhei Tsutsumi; Syuichi Muto; Toshiro Sugiyama; Takeshi Azuma; Masahiro Asaka; Masanori Hatakeyama
Journal:  Science       Date:  2001-12-13       Impact factor: 47.728

2.  A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori.

Authors:  Y Yamaoka; D H Kwon; D Y Graham
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase.

Authors:  Ryouhei Tsutsumi; Hideaki Higashi; Megumi Higuchi; Masato Okada; Masanori Hatakeyama
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

4.  Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori.

Authors:  Richard H Argent; Mark Kidd; Robert J Owen; Rachael J Thomas; Marie C Limb; John C Atherton
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

5.  Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.

Authors:  W K Leung; S-R Lin; J Y L Ching; K-F To; E K W Ng; F K L Chan; J Y W Lau; J J Y Sung
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

6.  Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.

Authors:  M Ito; K Haruma; T Kamada; M Mihara; S Kim; Y Kitadai; M Sumii; S Tanaka; M Yoshihara; K Chayama
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

7.  Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites.

Authors:  Hideaki Higashi; Ryouhei Tsutsumi; Akiko Fujita; Shiho Yamazaki; Masahiro Asaka; Takeshi Azuma; Masanori Hatakeyama
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

8.  Helicobacter pylori eradication treatment modulates epithelial cell proliferation and tissue content of hepatocyte growth factor in the gastric mucosa.

Authors:  M Suzuki; H Suzuki; T Masaoka; S Tanaka; K Suzuki; H Ishii
Journal:  Aliment Pharmacol Ther       Date:  2004-07       Impact factor: 8.171

9.  Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer.

Authors:  M Kato; M Asaka; Y Shimizu; A Nobuta; H Takeda; T Sugiyama
Journal:  Aliment Pharmacol Ther       Date:  2004-07       Impact factor: 8.171

10.  Individual and joint impact of family history and Helicobacter pylori infection on the risk of stomach cancer: a nested case-control study.

Authors:  H Yatsuya; H Toyoshima; A Tamakoshi; S Kikuchi; K Tamakoshi; T Kondo; T Mizoue; N Tokui; Y Hoshiyama; K Sakata; N Hayakawa; T Yoshimura
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

View more
  4 in total

1.  Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer.

Authors:  Hai-Bo Qiu; Li-Yi Zhang; Rajiv-Prasad Keshari; Guo-Qiang Wang; Zhi-Wei Zhou; Da-Zhi Xu; Wei Wang; You-Qin Zhan; Wei Li
Journal:  BMC Cancer       Date:  2010-07-17       Impact factor: 4.430

Review 2.  Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis.

Authors:  Lei Gao; Alexandra Nieters; Hermann Brenner
Journal:  Eur J Hum Genet       Date:  2009-06-17       Impact factor: 4.246

3.  Seroprevalence of anti-Helicobacter pylori and anti-cytotoxin-associated gene A antibodies among healthy individuals in center of Iran.

Authors:  Saeideh Afsharipour; Razieh Nazari; Masoumeh Douraghi
Journal:  Iran J Basic Med Sci       Date:  2014-08       Impact factor: 2.699

4.  ABO blood group system and gastric cancer: a case-control study and meta-analysis.

Authors:  Zhiwei Wang; Lei Liu; Jun Ji; Jianian Zhang; Min Yan; Jun Zhang; Bingya Liu; Zhenggang Zhu; Yingyan Yu
Journal:  Int J Mol Sci       Date:  2012-10-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.